Literature DB >> 25754935

Detection of Escherichia albertii from chicken meat and giblets.

Eriko Maeda1, Koichi Murakami, Nobuyuki Sera, Kenitiro Ito, Shuji Fujimoto.   

Abstract

Escherichia albertii occasionally causes food-borne outbreaks of gastroenteritis in humans; however, little is known about the vehicle of transmission. To screen retail chicken products for the presence of E. albertii, 104 retail chicken products were investigated. Portions of enrichment cultures that were PCR-positive for E. albertii (n=3) were sub-cultured on agar medium. Only 2 strains obtained from 2 chicken giblet samples were identified as E. albertii by multi locus sequence typing. Antimicrobial susceptibility testing showed that 1 strain was resistant to streptomycin and sulfisoxazole. Both strains harbored the virulence genes cdt and eae. This study is the first description of E. albertii isolation from retail food, suggesting that chicken products are a potential vehicle of E. albertii transmission.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754935      PMCID: PMC4527513          DOI: 10.1292/jvms.14-0640

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


Escherichia albertii can infect humans and birds, and was first described in 2003 [5]. E. albertii occasionally causes outbreaks of gastroenteritis in humans [1, 9, 15], yet the vehicle of this presumably foodborne pathogen remains unknown. Oaks et al. [12] reported that chickens harbor E. albertii; therefore, we suspected that chicken meat may be a vehicle for transmission of this enteropathogen to humans. It is important to identify the sources of contamination to help develop effective food hygiene protocols. The aim of the present study was to screen retail chicken meat and giblet samples for the presence of E. albertii. A total of 104 retail chicken meat (n=54: 15 thigh, 8 skin, 6 inner fillet, 5 mix of thigh and breast, 5 neck meat, 4 mince, 3 breast and 8 uncertain meat) and giblet (n=50: 42 liver, 4 crop, 2 heart and 2 reproductive tract) samples were collected from 10 supermarkets in Fukuoka Prefecture, Japan, between June and October 2014. Samples were incubated in 9 volumes of buffered peptone water (BPW) (Oxoid, Basingstoke, U.K.) at 35°C for 18 hr. Aliquots of each BPW culture were then centrifuged at 13,800 × g for 5 min, and the supernatant was discarded. The pellet was resuspended in normal saline (1 ml) and centrifuged at 13,800 × g for 5 min. The supernatant was discarded, and the pellet was resuspended in 1 ml of 0.1× TE buffer with 5% Chelex 100 (Bio-Rad Laboratories, Hercules, CA, U.S.A.) before being boiled for 10 min, and then centrifuged at 13,800 × g for 10 min. The supernatant was used as a template for a PCR assay to detect E. albertii using primer pair lysP107F/lysP358R, as described previously [6]. To isolate the pathogen, the remainder of the BPW cultures of the PCR-positive samples were streaked onto deoxycholate-hydrogen sulfide-lactose agar (Eiken Chemical Co., Tokyo, Japan) and incubated at 37°C overnight. Presumptive E. albertii colonies (50–100/sample) were isolated on nutrient agar plates (Eiken Chemical Co.) and incubated at 37°C overnight. The isolates were then re-tested using the PCR method described above. The confirmed PCR-positive isolates were then examined for fermentation of glucose, motility and hydrogen sulfide production on triple-sugar iron agar (Eiken Chemical Co.) and sulfide indole motility medium agar (Eiken Chemical Co.). Isolates with positive glucose fermentation, negative motility and negative hydrogen sulfide production test results were then confirmed as E. albertii using multi locus sequence typing (MLST) as previously described [9]. Sequences of isolates in the present study were submitted to MLST databases run by the University of Warwick (http://mlst.warwick.ac.uk/mlst/, accessed 5th October, 2014), and isolates were assigned sequence types (ST) defined by the database (http://mlst.warwick.ac.uk/mlst/dbs/Senterica/GetTableInfo_html). Allele sequences for each isolate were then concatenated in the order adk − fumC − gyrB − icd − mdh − purA − recA, for a final composite length of 3,423 bp. The concatenated sequences were aligned using ClustalW [21], and a phylogenetic tree was constructed using the neighbor-joining method in MEGA5 software [20] to compare the results with other published STs. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc-diffusion method, in accordance with the guidelines of the Clinical and Laboratory Standards Institute [2, 3]. Ampicillin, chloramphenicol, ciprofloxacin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, gentamicin, tetracycline and cefixime discs used for the test were purchased from Becton Dickinson (Franklin Lakes, NJ, U.S.A.). The presence of the virulence-related genes stx2f (Shiga toxin 2f gene) [10], cdt (cytolethal distending toxin gene) [18] and eae (intimin gene) [16] was also examined by PCR as described previously. PCR results showed that 2 enrichment cultures of chicken giblets (liver) and 1 chicken meat sample were positive for E. albertii. However, only 2 E. albertii strains, from the 2 chicken giblet samples, were subsequently isolated from the 104 chicken product samples tested. These samples were from different manufacturers and were obtained from different supermarkets. Both strains were identified as ST4633, and the phylogenetic tree confirmed that this ST is an E. albertii lineage (Fig. 1). The 2 E. albertii strains showed different resistance patterns, although both strains harbored the virulence-related genes eae and cdt, but not stx2f (Table 1).
Fig. 1.

Phylogenetic tree showing nucleotide sequence clusters of the tested Escherichia albertii strains obtained using multi-locus sequence typing. ST383, ST413, ST95 and ST2819 were included as outgroups. Reference sequences were tested in a previous study [9]. Shigella boydii serotype 13 ATCC 12032 has been reclassified into the Escherichia albertii lineage. The scale bar indicates the number of nucleotide substitutions per site.

Table 1.

Features of Escherichia albertii isolates in this study and in previous studies

E. albertiiisolatesOriginsNumberof strainstestedVirulence-related genesa)Antimicrobial resistance(ampicillin, chloramphenicol, ciprofloxacin, kanamycin,nalidixic acid, streptomycin, sulfisoxazole,gentamicin, tetracycline and cefixime)References

eaecdtstx2f
This study
ID 3428Chicken giblet+b)+c)Susceptible to all antimicrobials testedThis study
ID 3483Chicken giblet++Streptomycin and sulfisoxazoleThis study
Other studies
Birds29100%100%NTNTd)[12]
Birds9100%e)100%NTNT[13]
Birds11100%e)100%9.1%NT[14]
Feline1100%e)0%0%NT[14]
Swine1100%100%f)NTNT[4]
Humans4NTNTNTAmpicillin (0%), chloramphenicol (0%), kanamycin (0%) and tetracycline (100%)g)[5]
Humans48100%85%4.2%NT[11]
Humans14100%e)100%7.1%NT[14]
Humans21NTNTNTAmpicillin (14%), chloramphenicol (62%), ciprofloxacin (0%), kanamycin (0%), streptomycin (76%), gentamicin (0%), tetracycline (100%) and cefixime (0%)h)[19]
Humans1100%e)100%100%NT[9]
Environmental water180%83%0%NT[8]
Uncertain3NTNTNTAmpicillin (0%), chloramphenicol (0%), gentamicin (0%) and tetracycline (100%)i)[17]

a) eae: Intimin gene, cdt: Cytolethal distending toxin gene, stx2f: Shiga toxin 2f gene. b) +: Detected. c) –: Not detected. d) NT: Not tested. e) Only eae-positive isolates were used in this study. f) Only cdt-positive isolates were used in this study. g) Did not test with ciprofloxacin, nalidixic acid, streptomycin, sulfisoxazole, gentamicin or cefixime. h) Did not test with nalidixic acid or sulfisoxazole. i) Did not test with ciprofloxacin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole or cefixime.

Phylogenetic tree showing nucleotide sequence clusters of the tested Escherichia albertii strains obtained using multi-locus sequence typing. ST383, ST413, ST95 and ST2819 were included as outgroups. Reference sequences were tested in a previous study [9]. Shigella boydii serotype 13 ATCC 12032 has been reclassified into the Escherichia albertii lineage. The scale bar indicates the number of nucleotide substitutions per site. a) eae: Intimin gene, cdt: Cytolethal distending toxin gene, stx2f: Shiga toxin 2f gene. b) +: Detected. c) –: Not detected. d) NT: Not tested. e) Only eae-positive isolates were used in this study. f) Only cdt-positive isolates were used in this study. g) Did not test with ciprofloxacin, nalidixic acid, streptomycin, sulfisoxazole, gentamicin or cefixime. h) Did not test with nalidixic acid or sulfisoxazole. i) Did not test with ciprofloxacin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole or cefixime. These results show that retail chicken can be contaminated by E. albertii. The inability to isolate E. albertii from 1 of the 3 PCR-positive samples might be caused by a low density of the bacterium in the sample and/or non-specific annealing of the primer pair lysP107F/lysP358R, as described previously [7]. The virulence-related gene patterns of the 2 strains, showing positive for eae and cdt, and negative for stx2f, were similar to those of previous reports that showed that most reported E. albertii strains carry eae (114/132) [4, 8, 9, 11,12,13,14] and cdt (121/132) [4, 8, 9, 11,12,13,14], and several contain stx2f (5/93) [8, 9, 11, 14], including bird isolates (Table 1). Interestingly, both E. albertii strains from the current study were susceptible to tetracycline, although only one of the 2 strains was resistant to streptomycin and sulfisoxazole. This is in contrast to 3 previous studies [5, 17, 19], which reported that E. albertii was resistant to tetracycline (Table 1). The results of the current study show that E. albertii contamination of chicken giblets might pose a potential health risk to humans because of the presence of virulence-related and antimicrobial resistance factors. To the best of our knowledge, the present study is the first description of E. albertii isolation from retail food, although E. albertii has previously been isolated from birds, including chickens [12], feline [14] and swine [4]. Because only 104 samples collected from a small area were tested in the present study, further analyses are needed to determine the prevalence of E. albertii in chicken products. However, this study supports the hypothesis that chicken products might be a potential vehicle of E. albertii transmission. Sequences of strains in the present study were submitted to MLST databases run by the University of Warwick (http://mlst.warwick.ac.uk/mlst/) as ST4633.
  19 in total

1.  Epidemiological investigation of eaeA-positive Escherichia coli and Escherichia albertii strains isolated from healthy wild birds.

Authors:  Jae-Young Oh; Min-Su Kang; Hee-Tae Hwang; Byung-Ki An; Jun-Hun Kwon; Yong-Kuk Kwon
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

2.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

3.  Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

Authors:  C L Pickett; E C Pesci; D L Cottle; G Russell; A N Erdem; H Zeytin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Nonspecificity of primers for Escherichia albertii detection.

Authors:  Eriko Maeda; Koichi Murakami; Fuyuki Okamoto; Yoshiki Etoh; Nobuyuki Sera; Kenitiro Ito; Shuji Fujimoto
Journal:  Jpn J Infect Dis       Date:  2014       Impact factor: 1.362

5.  Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157.

Authors:  A W Paton; J C Paton
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains.

Authors:  Ingo Stock; Motiur Rahman; Kimberley Jane Sherwood; Bernd Wiedemann
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

8.  Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains.

Authors:  Katie E Hyma; David W Lacher; Adam M Nelson; Alyssa C Bumbaugh; J Michael Janda; Nancy A Strockbine; Vincent B Young; Thomas S Whittam
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

9.  Subtyping of Shiga toxin 2 variants in human-derived Shiga toxin-producing Escherichia coli strains isolated in Japan.

Authors:  Hiroshi Nakao; Kouichi Kimura; Hiroyuki Murakami; Tsutomu Maruyama; Tae Takeda
Journal:  FEMS Immunol Med Microbiol       Date:  2002-12-13

10.  Escherichia albertii in wild and domestic birds.

Authors:  J Lindsay Oaks; Thomas E Besser; Seth T Walk; David M Gordon; Kimberlee B Beckmen; Kathy A Burek; Gary J Haldorson; Dan S Bradway; Lindsey Ouellette; Fred R Rurangirwa; Margaret A Davis; Greg Dobbin; Thomas S Whittam
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

View more
  5 in total

Review 1.  Microbiology and Epidemiology of Escherichia albertii-An Emerging Elusive Foodborne Pathogen.

Authors:  Francis Muchaamba; Karen Barmettler; Andrea Treier; Kurt Houf; Roger Stephan
Journal:  Microorganisms       Date:  2022-04-22

Review 2.  The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii.

Authors:  Shantanu Bhatt; Marisa Egan; Brian Critelli; Andrew Kouse; Daniel Kalman; Chirag Upreti
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

3.  Prevalence of eae-positive, lactose non-fermenting Escherichia albertii from retail raw meat in China.

Authors:  H Wang; Q Li; X Bai; Y Xu; A Zhao; H Sun; J Deng; B Xiao; X Liu; S Sun; Y Zhou; B Wang; Z Fan; X Chen; Z Zhang; J Xu; Y Xiong
Journal:  Epidemiol Infect       Date:  2015-05-25       Impact factor: 4.434

4.  Multidrug-Resistant Escherichia albertii: Co-occurrence of β-Lactamase and MCR-1 Encoding Genes.

Authors:  Qun Li; Hong Wang; Yanmei Xu; Xiangning Bai; Jianping Wang; Zhengdong Zhang; Xiang Liu; Yimao Miao; Ling Zhang; Xinqiong Li; Nianli Zou; Guodong Yan; Xi Chen; Jie Zhang; Shanshan Fu; Ruyue Fan; Jianguo Xu; Juan Li; Yanwen Xiong
Journal:  Front Microbiol       Date:  2018-02-16       Impact factor: 5.640

5.  Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia.

Authors:  Linda Grillová; Ivo Sedláček; Gabriela Páchníková; Eva Staňková; Pavel Švec; Pavla Holochová; Lenka Micenková; Juraj Bosák; Iva Slaninová; David Šmajs
Journal:  J Vet Med Sci       Date:  2017-12-15       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.